Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,850,820
+$1,115,845 QoQ
Shares Held
4,878
-5.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
#1,589
of 4,605 holders
Holding Since
Dec 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GARDNER LEWIS ASSET MANAGEMENT L P holds $6,880,577 across 2 Drug Manufacturers - General names. LLY ranks #1 (85.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
4,878 | $5,850,820 | |
| 2 | OGN |
Organon & Co.
|
76,053 | $1,029,757 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,850,820 | 4,878 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,734,975 | 5,148 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,619,502 | 5,229 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,766,931 | 4,937 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,890,634 | 4,991 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,002,359 | 4,846 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,889,856 | 2,448 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,170,553 | 2,450 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,218,181 | 2,450 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,906,002 | 2,450 | Shares | Sole | 2024-05-13 | |
| 2021-12-31 | $1,647,928 | 5,966 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||